Valuation: Highnoon Laboratories Limited

Market Cap 5.04TCr 18Cr 16Cr 15Cr 14Cr 26Cr 1.74TCr 26Cr 180.53Cr 70Cr 891.31Cr 68Cr 67Cr 2.86TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 5.04TCr 18Cr 16Cr 15Cr 14Cr 26Cr 1.74TCr 26Cr 180.53Cr 70Cr 891.31Cr 68Cr 67Cr 2.86TCr EV / Sales 2026 *
1.66x
EV / Sales 2027 * 1.48x
Free-Float
50.02%
Yield 2026 *
4.73%
Yield 2027 * 5.46%
1 day-0.07%
1 week+2.51%
Current month+1.79%
1 month-1.94%
3 months-4.64%
6 months+6.28%
Current year-6.93%
1 week 930
Extreme 930
965
1 month 904.01
Extreme 904.01
979.9
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,224
3 years 360.11
Extreme 360.11
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.855793
1,241
Manager TitleAgeSince
Chief Executive Officer - 01/04/2015
Chief Executive Officer 63 01/01/1996
Director of Finance/CFO - 01/04/2020
Director TitleAgeSince
Chairman - 07/09/2012
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.07%+2.51%-16.53%+157.24% 18Cr
+0.13%+2.65%+65.61%+114.28% 1,05500Cr
+0.20%+0.46%+52.60%+69.24% 65TCr
-0.29%+0.14%+20.96%+70.93% 47TCr
-0.85%+0.98%+41.29%+44.38% 35TCr
+0.71%+4.08%+22.24%+29.51% 27TCr
+1.23%+0.42%+14.57%+12.13% 26TCr
+2.11%+7.51%+52.89%+55.37% 22TCr
+0.83%+0.55%+35.99%+101.70% 19TCr
0.00%-10.14%-29.94%-60.30% 17TCr
Average +0.32%+0.80%+25.97%+59.45% 36.39TCr
Weighted average by Cap. +0.02%+1.32%+41.53%+67.84%

Financials

2026 *2027 *
Net sales 3.04TCr 11Cr 9.63Cr 9.1Cr 8.29Cr 16Cr 1.05TCr 16Cr 108.84Cr 42Cr 537.38Cr 41Cr 40Cr 1.73TCr 3.42TCr 12Cr 11Cr 10Cr 9.32Cr 17Cr 1.18TCr 18Cr 122.32Cr 47Cr 603.94Cr 46Cr 45Cr 1.94TCr
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
25/26/25 PKR 951.59 -0.07% 4,382
24/26/24 PKR 952.25 -0.73% 3,336
23/26/23 PKR 959.21 +1.19% 6,756
22/26/22 PKR 947.96 +1.01% 3,541
21/26/21 PKR 938.51 +1.10% 7,301
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
951.59PKR
Average target price
1,121.00PKR
Spread / Average Target
+17.80%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock